戻る
Bone Biologics Corp (BBLG) 収入
BBLG 株価推移チャート
BBLG 収入
Bone Biologics Corp
$1.1
1.85%
$0.02
終値： Mar 31, 16:00:00 GMT-4
$1.16
5.45%
$0.05
アフターマーケット：Mar 31, 20:00:00 GMT-4
最新の利益結果: Q4 '25
報告済み: 2026-03-02
歴史的収益
四半期
年次
EPS
収入
Earnings FAQ
BBLGの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Bone Biologics Corp BBLGの前四半期の収益はどうでしたか？
Bone Biologics Corpの収益見積もりはいくらですか？
Bone Biologics Corpの収益品質スコアはどれくらいですか？
Bone Biologics Corpはいつ収益を報告しますか？
Bone Biologics Corpの予想収益はいくらですか？
Bone Biologics Corpは収益予想を上回りましたか？
主要データ
前終値
$1.08
始値
$1.08
当日レンジ
$1.08 - $1.16
52週レンジ
$1.05 - $6.75
取引高
8.3K
平均取引高
25.9K
配当利回り
--
1株当たり利益(TTM)
-4.00
時価総額
$2.0M
BBLGとは何ですか？
Bone Biologics Corp. operates as a medical device company. The company is headquartered in Burlington, Massachusetts and currently employs 2 full-time employees. The company went IPO on 2015-11-27. The firm is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.